These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


336 related items for PubMed ID: 31102980

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Structure versus function-The impact of computational methods on the discovery of specific GPCR-ligands.
    Bermudez M, Wolber G.
    Bioorg Med Chem; 2015 Jul 15; 23(14):3907-12. PubMed ID: 25828056
    [Abstract] [Full Text] [Related]

  • 6. Improving virtual screening of G protein-coupled receptors via ligand-directed modeling.
    Coudrat T, Simms J, Christopoulos A, Wootten D, Sexton PM.
    PLoS Comput Biol; 2017 Nov 15; 13(11):e1005819. PubMed ID: 29131821
    [Abstract] [Full Text] [Related]

  • 7. Efficiency of Homology Modeling Assisted Molecular Docking in G-protein Coupled Receptors.
    Bhunia SS, Saxena AK.
    Curr Top Med Chem; 2021 Nov 15; 21(4):269-294. PubMed ID: 32901584
    [Abstract] [Full Text] [Related]

  • 8. Reliability of Docking-Based Virtual Screening for GPCR Ligands with Homology Modeled Structures: A Case Study of the Angiotensin II Type I Receptor.
    Chen H, Fu W, Wang Z, Wang X, Lei T, Zhu F, Li D, Chang S, Xu L, Hou T.
    ACS Chem Neurosci; 2019 Jan 16; 10(1):677-689. PubMed ID: 30265513
    [Abstract] [Full Text] [Related]

  • 9. Structure-based and fragment-based GPCR drug discovery.
    Andrews SP, Brown GA, Christopher JA.
    ChemMedChem; 2014 Feb 16; 9(2):256-75. PubMed ID: 24353016
    [Abstract] [Full Text] [Related]

  • 10. Allosteric Modulation of Class A GPCRs: Targets, Agents, and Emerging Concepts.
    Wold EA, Chen J, Cunningham KA, Zhou J.
    J Med Chem; 2019 Jan 10; 62(1):88-127. PubMed ID: 30106578
    [Abstract] [Full Text] [Related]

  • 11. How Do Molecular Dynamics Data Complement Static Structural Data of GPCRs.
    Torrens-Fontanals M, Stepniewski TM, Aranda-García D, Morales-Pastor A, Medel-Lacruz B, Selent J.
    Int J Mol Sci; 2020 Aug 18; 21(16):. PubMed ID: 32824756
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Methods for Virtual Screening of GPCR Targets: Approaches and Challenges.
    Cross JB.
    Methods Mol Biol; 2018 Aug 18; 1705():233-264. PubMed ID: 29188566
    [Abstract] [Full Text] [Related]

  • 15. Discovery of new GPCR ligands to illuminate new biology.
    Roth BL, Irwin JJ, Shoichet BK.
    Nat Chem Biol; 2017 Nov 18; 13(11):1143-1151. PubMed ID: 29045379
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Structure-based molecular modeling approaches to GPCR oligomerization.
    Kaczor AA, Selent J, Poso A.
    Methods Cell Biol; 2013 Nov 18; 117():91-104. PubMed ID: 24143973
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery.
    Persechino M, Hedderich JB, Kolb P, Hilger D.
    Pharmacol Ther; 2022 Sep 18; 237():108242. PubMed ID: 35863587
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.